Bartlett & Co Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Bartlett & Co Wealth Management's XBI Position: Q3 2026 in Review
Bartlett & Co Wealth Management held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q3 2026 at 3,120 shares worth $492K. The position accounts for 0.01% of the portfolio, ranked #348.
Bartlett & Co Wealth Management first reported a position in XBI in Q1 2018 and has held it in 35 quarters since. The position peaked at $555K in Q4 2020. 963 funds tracked by Wall St. Rank hold XBI as of Q3 2026.
- Bartlett & Co Wealth Management held 3,120 shares of State Street SPDR S&P Biotech ETF worth $492K as of Q3 2026.
- Bartlett & Co Wealth Management left its State Street SPDR S&P Biotech ETF share count unchanged in Q3 2026.
- State Street SPDR S&P Biotech ETF made up 0.01% of Bartlett & Co Wealth Management's portfolio in Q3 2026, its #348 holding.
- Bartlett & Co Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2018 and has held it in 35 quarters since.
- Bartlett & Co Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $555K in Q4 2020.
- 963 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.
Based on Bartlett & Co Wealth Management's 13F filing for Q3 2026, filed 12 Nov 2026.